Last 46 quarters of trend data · Real Estate · REIT - Healthcare Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
EV/EBITDA has compressed 27.7% YoY to 6.7x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 115.29 | — | — | — | 13.84 | 18.56 | 18.22 | — | 180.49 | 59.04 | 6.40 | 2.54 | 14.02 |
| — | — | — | — | -92.3% | -68.6% | +184.7% | — | +1187.8% | — | +80.2% | -86.4% | +8.2% | |
| P/S Ratio | 0.68 | 3.21 | 2.78 | 0.61 | 0.85 | 0.74 | 0.95 | 0.87 | 0.82 | 1.10 | 0.83 | 0.82 | 0.82 |
| — | +334.4% | +191.7% | -29.7% | +3.4% | -33.2% | +15.0% | +5.7% | -0.7% | +29.2% | +5.1% | -24.6% | -50.7% | |
| P/B Ratio | 0.17 | 0.85 | 0.89 | 0.18 | 0.22 | 0.19 | 0.23 | 0.21 | 0.19 | 0.24 | 0.19 | 0.19 | 0.19 |
| — | +358.5% | +286.4% | -14.3% | +13.2% | -22.7% | +24.3% | +10.4% | +1.2% | +25.5% | +10.5% | -17.7% | -41.8% | |
| P/FCF | — | — | 1.22 | — | — | — | 1.51 | 1.89 | 2.33 | 2.54 | 2.22 | 1.88 | 1.99 |
| — | — | -19.6% | — | — | — | -31.9% | +0.7% | +17.0% | +34.1% | — | — | — | |
| EV / EBITDA | 8.35 | 6.71 | 10.67 | 8.59 | 8.51 | 9.28 | 8.48 | 8.20 | 7.95 | 8.37 | 6.93 | 4.98 | 8.02 |
| — | -27.7% | +25.8% | +4.8% | +7.0% | +10.9% | +22.4% | +64.7% | -0.9% | +38.4% | -13.6% | -8.9% | -9.9% | |
| EV / EBIT | 22.68 | 112.31 | — | 23.64 | 18.43 | 17.93 | 17.99 | 36.69 | 20.20 | 25.32 | 15.23 | 18.75 | 15.28 |
| — | +526.2% | — | -35.6% | -8.8% | -29.2% | +18.1% | +95.7% | +32.2% | +21.7% | -19.5% | -13.0% | -41.7% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | 42.7% | 78.3% | 78.1% | 79.4% | 78.2% | 78.9% | 78.9% | 81.5% | 79.6% | 100.0% | 79.2% |
| — | — | -45.4% | -0.7% | -1.1% | -2.6% | -1.7% | -21.1% | -0.3% | -18.3% | -1.9% | +0.3% | -4.7% | |
| Operating Margin | — | — | 30.7% | 22.0% | 27.6% | 18.3% | 25.5% | 24.5% | 26.1% | 25.4% | — | 64.2% | 27.6% |
| — | — | +20.6% | -10.2% | +5.9% | -27.9% | — | -61.8% | -5.4% | -54.0% | — | -7.0% | -3.6% | |
| Net Margin | -8.2% | -33.5% | -11.2% | 1.7% | 10.3% | 8.1% | 9.5% | -4.9% | 6.4% | 1.9% | 12.9% | 36.5% | 5.9% |
| — | -513.8% | -218.0% | +135.0% | +60.4% | +332.8% | -26.6% | -113.5% | +9.2% | -62.8% | -43.1% | +233.4% | -54.5% |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -2.2% | -2.3% | -0.9% | 0.1% | 0.7% | 0.5% | 0.6% | -0.3% | 0.4% | 0.1% | 0.7% | 2.1% | 0.3% |
| — | -550.4% | -255.3% | +142.8% | +74.0% | +408.1% | -21.2% | -113.8% | +12.2% | -64.2% | -41.3% | +268.7% | -47.8% | |
| ROA | -1.0% | -0.9% | -0.4% | 0.1% | 0.3% | 0.2% | 0.3% | -0.1% | 0.2% | 0.0% | 0.4% | 1.0% | 0.2% |
| — | -513.6% | -235.3% | +137.7% | +58.6% | +372.9% | -25.4% | -113.7% | +15.3% | -63.2% | -39.9% | +253.4% | -52.3% | |
| ROIC | — | — | 0.8% | 0.5% | 0.6% | 0.4% | 0.5% | 0.5% | 0.6% | 0.5% | — | 1.4% | 0.6% |
| — | — | +38.8% | -2.4% | +5.2% | -21.3% | — | -61.9% | -0.7% | -54.4% | — | -1.1% | +0.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | 1.44 | 1.38 | 1.29 | 1.18 | 1.13 | 1.08 | 1.06 | 1.02 | 1.00 | 1.00 | 1.12 |
| — | — | +27.1% | +28.0% | +21.9% | +15.8% | +13.8% | +8.5% | -5.5% | -5.9% | -6.0% | -3.6% | +22.0% | |
| Debt / EBITDA | — | — | 26.52 | 30.74 | 29.32 | 32.38 | 28.40 | 27.75 | 26.96 | 27.16 | 23.93 | 17.23 | 28.21 |
| — | — | -6.6% | +10.7% | +8.8% | +19.2% | +18.7% | +61.1% | -4.4% | +31.4% | -15.8% | -6.6% | +5.3% | |
| Current Ratio | — | — | 0.53 | 1.32 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | — | — | — |
| — | — | +1812.9% | +4751.3% | -8.7% | +11.5% | — | — | — | -49.1% | — | — | — | |
| Quick Ratio | — | — | 0.53 | 1.32 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | — | — | — |
| — | — | +1812.9% | +4751.3% | -8.7% | +11.5% | — | — | — | -49.1% | — | — | — | |
| Interest Coverage | 0.62 | 0.12 | -0.44 | 1.07 | 1.52 | 1.39 | 1.47 | 0.72 | 1.34 | 1.08 | 1.67 | 1.16 | 1.58 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 46 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying GMRE stock.
Global Medical REIT Inc.'s current P/E is 115.3x. The average P/E over the last 1 quarters is 13.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Global Medical REIT Inc.'s business trajectory between earnings reports.